CAS: 1001908-89-9 - SRT2183
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
(R)-N-(2-(3-((3-hydroxypyrrolidin-1-yl)Methyl)iMidazo[2,1-b]thiazol-6-yl)phenyl)-2-naphthaMide REF: IN-DA0092WDCAS: 1001908-89-9 | 99% | A consultar | Mar 10 Dic 24 | |
SRT 2183 REF: TM-T16932CAS: 1001908-89-9 | 97.86% | 50,00 €~609,00 € | Lun 16 Dic 24 | |
SRT 2183 REF: 3D-BQB90889CAS: 1001908-89-9 | Min. 95% | A consultar | Mar 21 Ene 25 |
(R)-N-(2-(3-((3-hydroxypyrrolidin-1-yl)Methyl)iMidazo[2,1-b]thiazol-6-yl)phenyl)-2-naphthaMide
CAS:1001908-89-9
Fórmula:
C27H24N4O2S
Pureza:
99%
Peso molecular:
468.5701
Ref: IN-DA0092WD
1mg | 79,00 € | ||
5mg | 116,00 € | ||
10mg | 142,00 € | ||
25mg | 154,00 € | ||
50mg | 259,00 € | ||
100mg | 586,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
SRT 2183
CAS:1001908-89-9
SRT 2183 is a selective activator of Sirtuin-1 (SIRT1, EC1.5 : 0.36 μM).
Fórmula:
C27H24N4O2S
Pureza:
97.86%
Forma y color:
Solid
Peso molecular:
468.57
Ref: TM-T16932
1mg | 50,00 € | ||
2mg | 71,00 € | ||
5mg | 106,00 € | ||
10mg | 162,00 € | ||
25mg | 276,00 € | ||
50mg | 423,00 € | ||
100mg | 609,00 € | ||
1mL*10mM (DMSO) | 111,00 € |
Entrega estimada en Estados Unidos, el Lunes 16 de Diciembre de 2024
SRT 2183
CAS:1001908-89-9
SRT 2183 is an experimental drug that has been shown to have anti-cancer properties. It …
Fórmula:
C27H24N4O2S
Pureza:
Min. 95%
Peso molecular:
468.57 g/mol
Ref: 3D-BQB90889
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025